Bioelectrochemistry of Proteins

蛋白质生物电化学

• 批准号: 1000231116-2015
• 负责人: Kerman, Kagan
• 金额: $ 8.74万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=695979
• 关键词: Bioelectrochemistry; Proteins

Kermans research will provide next-generation, accelerated analytical methods and bioelectrochemical technologies/biosensors to understand the biomolecular interactions/mechanisms of Alzheimers disease (AD). To address the urgent human need for effective AD treatment, the proposed research program will accelerate AD therapeutics screening. His cutting-edge research results will benefit the Canadian economy by alleviating AD-associated costs; build translational research, through fostering biosensor applications to multiple subsectors (medical devices / biotechnology, pharmaceuticals, food and forensics); and position Canada, especially Ontario, through training next-generation HQP, as a leader in biosensor research.

Kermans的研究将提供下一代加速分析方法和生物电化学技术/生物传感器，以了解阿尔茨海默病（AD）的生物分子相互作用/机制。为了解决人类对有效治疗阿尔茨海默病的迫切需求，拟议的研究项目将加速阿尔茨海默病治疗药物的筛选。他的前沿研究成果将减轻ad相关成本，从而有利于加拿大经济；通过促进生物传感器在多个子行业（医疗设备/生物技术、制药、食品和法医）的应用，建立转化研究；通过培养下一代HQP，使加拿大，特别是安大略省成为生物传感器研究的领导者。